148 related articles for article (PubMed ID: 17348833)
41. [Mechanisms of action of and resistance to rifampicin and isoniazid in Mycobacterium tuberculosis: new information on old friends].
De La Iglesia AI; Morbidoni HR
Rev Argent Microbiol; 2006; 38(2):97-109. PubMed ID: 17037259
[TBL] [Abstract][Full Text] [Related]
42. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase.
Mahnashi MH; Avunoori S; Gopi S; Shaikh IA; Saif A; Bantun F; Faidah HS; Alhadi AA; Alshehri JH; Alharbi AA; S R PK; Joshi SD
PLoS One; 2024; 19(5):e0303173. PubMed ID: 38739587
[TBL] [Abstract][Full Text] [Related]
44. Biochemical and structural characterization of the trans-enoyl-CoA reductase from Treponema denticola.
Bond-Watts BB; Weeks AM; Chang MC
Biochemistry; 2012 Aug; 51(34):6827-37. PubMed ID: 22906002
[TBL] [Abstract][Full Text] [Related]
45. Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors.
da Silva Lima CH; de Alencastro RB; Kaiser CR; de Souza MV; Rodrigues CR; Albuquerque MG
Int J Mol Sci; 2015 Oct; 16(10):23695-722. PubMed ID: 26457706
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.
Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC
Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563
[TBL] [Abstract][Full Text] [Related]
47. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
[TBL] [Abstract][Full Text] [Related]
48. N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.
Guardia A; Gulten G; Fernandez R; Gómez J; Wang F; Convery M; Blanco D; Martínez M; Pérez-Herrán E; Alonso M; Ortega F; Rullás J; Calvo D; Mata L; Young R; Sacchettini JC; Mendoza-Losana A; Remuiñán M; Ballell Pages L; Castro-Pichel J
ChemMedChem; 2016 Apr; 11(7):687-701. PubMed ID: 26934341
[TBL] [Abstract][Full Text] [Related]
49. Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis.
Tripathi A; Wadia N; Bindal D; Jana T
Indian J Biochem Biophys; 2012 Dec; 49(6):435-41. PubMed ID: 23350278
[TBL] [Abstract][Full Text] [Related]
50. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.
Kapoor M; Dar MJ; Surolia A; Surolia N
Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121
[TBL] [Abstract][Full Text] [Related]
51. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Neves BJ; Bueno RV; Braga RC; Andrade CH
Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
[TBL] [Abstract][Full Text] [Related]
52. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
Lindert S; Tallorin L; Nguyen QG; Burkart MD; McCammon JA
J Comput Aided Mol Des; 2015 Jan; 29(1):79-87. PubMed ID: 25344312
[TBL] [Abstract][Full Text] [Related]
53. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
Suguna K; Surolia A; Surolia N
Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792
[TBL] [Abstract][Full Text] [Related]
54. Panosialins, inhibitors of enoyl-ACP reductase from Streptomyces sp. AN1761.
Kwon YJ; Sohn MJ; Oh T; Cho SN; Kim CJ; Kim WG
J Microbiol Biotechnol; 2013 Feb; 23(2):184-8. PubMed ID: 23412060
[TBL] [Abstract][Full Text] [Related]
55. Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.
Jordan CA; Sandoval BA; Serobyan MV; Gilling DH; Groziak MP; Xu HH; Vey JL
Acta Crystallogr F Struct Biol Commun; 2015 Dec; 71(Pt 12):1521-30. PubMed ID: 26625295
[TBL] [Abstract][Full Text] [Related]
56. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
Banerjee T; Sharma SK; Surolia N; Surolia A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
[TBL] [Abstract][Full Text] [Related]
57. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase.
Frecer V; Megnassan E; Miertus S
Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192
[TBL] [Abstract][Full Text] [Related]
58. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
Kumar SP; George LB; Jasrai YT; Pandya HA
SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
[TBL] [Abstract][Full Text] [Related]
59. Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).
Lu X; Huang K; You Q
Expert Opin Ther Pat; 2011 Jul; 21(7):1007-22. PubMed ID: 21651455
[TBL] [Abstract][Full Text] [Related]
60. Marine natural products from the Turkish sponge Agelas oroides that inhibit the enoyl reductases from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli.
Tasdemir D; Topaloglu B; Perozzo R; Brun R; O'Neill R; Carballeira NM; Zhang X; Tonge PJ; Linden A; Rüedi P
Bioorg Med Chem; 2007 Nov; 15(21):6834-45. PubMed ID: 17765547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
